2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q3 2023. The put-call ratio across all filers is 3.19 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 5,953,825 | $23,338,994 | 3.82% |
Newtyn Management, LLC | 3,076,490 | $12,059,841 | 2.98% |
DAFNA Capital Management LLC | 1,447,465 | $5,674,063 | 1.76% |
CHI Advisors LLC | 1,002,007 | $3,927,867 | 1.56% |
AlphaCentric Advisors LLC | 657,500 | $2,577,400 | 1.46% |
Casdin Capital, LLC | 2,023,913 | $7,933,739 | 0.88% |
Madison Avenue Partners, LP | 1,494,125 | $5,856,970 | 0.83% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $5,522,892 | 0.62% |
Eversept Partners, LP | 1,453,378 | $5,697,242 | 0.48% |
Engine Capital Management, LP | 341,870 | $1,340,130 | 0.30% |
CLOUGH CAPITAL PARTNERS L P | 510,910 | $2,002,767 | 0.22% |
Birchview Capital, LP | 59,833 | $234,545 | 0.20% |
Boxer Capital, LLC | 459,836 | $1,802,557 | 0.10% |
BROWN WEALTH MANAGEMENT, LLC | 50,000 | $196,000 | 0.09% |
SHERBROOKE PARK ADVISERS LLC | 57,432 | $225,133 | 0.07% |
Quantamental Technologies LLC | 19,109 | $74,907 | 0.07% |
Virtus ETF Advisers LLC | 28,308 | $110,967 | 0.07% |
Baker Brothers Advisors | 2,497,526 | $9,790,302 | 0.06% |
ExodusPoint Capital Management, LP | 1,389,953 | $5,449 | 0.05% |
ELCO Management Co., LLC | 17,051 | $66,840 | 0.05% |
This page lists 2SEVENTY BIO INC's shareholders in Q3 2023. To view 2SEVENTY BIO INC's shareholder history, click here.